Peripheral Artery Disease clinical trials
89 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Response to Exercise and Nitric Oxide in PAD
- The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
- Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
- Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Fisetin to Reduce Senescence and Mobility Impairment in PAD
- The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
- Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)
- Exercise Therapy for PAD Using Mobile Health
- Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
- Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
- MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
- Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Prehabilitation and Rehabilitation in PAD
- REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
- Vascular Trial Associated Registry Pilot
- Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
- EVERO Drug-coated Balloon (DCB) Randomized Trial
- SELUTION4BTK Trial
- SMART Exercise for PAD
- Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
- BEETroot Juice to Reverse Functional Impairment in PAD
- Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- Leg Heat Therapy in Peripheral Artery Disease
- PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- Improving Mobility After Revascularization in Peripheral Artery Disease
- MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- Passive Calf Stretching Therapy in Peripheral Artery Disease
- Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
- Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease
- Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
- The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Community-based Exercise Following Revascularization for PAD
- Augmentation of Limb Perfusion With Contrast Ultrasound
- The COCOA-PAD II Trial
- Passive Stretching in Peripheral Arterial Disease Patients
- Ultrasound Cavitation Therapy for CLI
- ENhancing Exercise With LIGHT to Improve Functioning in PAD
- The THOR IDE Study
- Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
- FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
- Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation
- Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Detecting Peripheral Artery Disease With the Pulse
- Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Peripheral Artery Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.